Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 7109 | 392 | 2.1297 | 1.5833 | 0.0551 | 0.0617 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 3287 | 185 | 0.9835 | 0.8880 | 0.0563 | 0.0519 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 3000 | 167 | 0.8982 | 0.8880 | 0.0557 | 0.0519 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2580 | 113 | 0.7822 | 0.8880 | 0.0438 | 0.0519 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 4472 | 217 | 1.3491 | 0.9268 | 0.0485 | 0.0478 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 3244 | 144 | 0.9829 | 0.9268 | 0.0444 | 0.0478 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 1489 | 75 | 0.4483 | 0.9268 | 0.0504 | 0.0478 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 2075 | 115 | 0.6214 | 0.7710 | 0.0554 | 0.0544 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2697 | 158 | 0.8050 | 0.7710 | 0.0586 | 0.0544 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 2941 | 145 | 0.8865 | 0.7710 | 0.0493 | 0.0544 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2107 | 125 | 0.6284 | 0.8443 | 0.0593 | 0.0545 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 3036 | 153 | 0.9141 | 0.8443 | 0.0504 | 0.0545 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 3 | 3302 | 178 | 0.9905 | 0.8443 | 0.0539 | 0.0545 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2574 | 151 | 0.7682 | 0.5584 | 0.0587 | 0.0586 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 2 | 2096 | 111 | 0.6294 | 0.5584 | 0.0530 | 0.0586 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 936 | 60 | 0.2777 | 0.5584 | 0.0641 | 0.0586 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 2958 | 221 | 0.8678 | 0.5805 | 0.0747 | 0.0771 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 1901 | 140 | 0.5583 | 0.5805 | 0.0736 | 0.0771 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 3 | 1085 | 90 | 0.3155 | 0.5805 | 0.0829 | 0.0771 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 1462 | 72 | 0.4407 | 0.5486 | 0.0492 | 0.0710 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 1878 | 154 | 0.5466 | 0.5486 | 0.0820 | 0.0710 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2262 | 185 | 0.6585 | 0.5486 | 0.0818 | 0.0710 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 1203 | 114 | 0.3453 | 0.4369 | 0.0948 | 0.0888 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 1571 | 141 | 0.4534 | 0.4369 | 0.0898 | 0.0888 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 1759 | 144 | 0.5120 | 0.4369 | 0.0819 | 0.0888 |